This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Among the hundreds of thousands of chemical compounds produced by plants, some may hold the key to treating human ailments and diseases. But recreating these complex, naturally occurring molecules in ...

Selected preclinical small molecule candidates will now be tested through the Quris-AI platform prior to initiating clinical trials. This follows a successful two-year validation study with Merck KGaA ...

Self-driving cars, specialized robots for medical procedures or factory work, and general-purpose robots as home assistants ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

In a time when personalized solutions are reshaping industries, Harpreet Singh’s work explores the profound influence of Big ...

Finding new medicines has always been a long, expensive, and complicated process. Scientists need to identify the right targets in the body, test thousands of potential compounds, and spend years in ...